每經(jing)AI快訊(xun)，7月18日，復(fu)旦復(fu)華(hua)發(fa)布股(gu)票交易(yi)異(yi)常波動公(gong)(gong)(gong)(gong)告，公(gong)(gong)(gong)(gong)司(si)(si)(si)、公(gong)(gong)(gong)(gong)司(si)(si)(si)控(kong)(kong)股(gu)股(gu)東和實(shi)際控(kong)(kong)制(zhi)人不(bu)存在涉及(ji)公(gong)(gong)(gong)(gong)司(si)(si)(si)的應披(pi)(pi)露(lu)而未披(pi)(pi)露(lu)的重大信息。公(gong)(gong)(gong)(gong)司(si)(si)(si)于(yu)(yu)(yu)7月18日披(pi)(pi)露(lu)了《上(shang)海(hai)(hai)復(fu)旦復(fu)華(hua)科(ke)技(ji)股(gu)份有限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)涉及(ji)仲(zhong)(zhong)(zhong)裁(cai)的進展公(gong)(gong)(gong)(gong)告》，對(dui)于(yu)(yu)(yu)田曉麗、李輝、寧波保稅區恒(heng)昇管理咨詢(xun)合(he)伙(huo)企業(有限(xian)合(he)伙(huo))、上(shang)海(hai)(hai)佰(bai)花深(shen)處(chu)(chu)醫療科(ke)技(ji)有限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)向上(shang)海(hai)(hai)國(guo)(guo)(guo)際經(jing)濟貿易(yi)仲(zhong)(zhong)(zhong)裁(cai)委員會（上(shang)海(hai)(hai)國(guo)(guo)(guo)際仲(zhong)(zhong)(zhong)裁(cai)中心）（簡稱(cheng)“上(shang)國(guo)(guo)(guo)仲(zhong)(zhong)(zhong)”）提起(qi)的《關(guan)于(yu)(yu)(yu)寧波美麗人生醫藥(yao)生物科(ke)技(ji)發(fa)展有限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)之(zhi)股(gu)權收購協議》爭議的仲(zhong)(zhong)(zhong)裁(cai)申請(qing)，公(gong)(gong)(gong)(gong)司(si)(si)(si)提起(qi)仲(zhong)(zhong)(zhong)裁(cai)反(fan)請(qing)求申請(qing)，上(shang)國(guo)(guo)(guo)仲(zhong)(zhong)(zhong)已受理。由(you)于(yu)(yu)(yu)本次(ci)仲(zhong)(zhong)(zhong)裁(cai)處(chu)(chu)于(yu)(yu)(yu)案(an)件受理初期，暫無法(fa)準確判斷對(dui)公(gong)(gong)(gong)(gong)司(si)(si)(si)損益的影(ying)響。公(gong)(gong)(gong)(gong)司(si)(si)(si)將積(ji)極(ji)采取相關(guan)法(fa)律措施，維(wei)護公(gong)(gong)(gong)(gong)司(si)(si)(si)及(ji)股(gu)東合(he)法(fa)權益，根據案(an)件進展情況(kuang)及(ji)時履行信息披(pi)(pi)露(lu)義務。